Relationship between exposure to pazopanib (P) and efficacy in patients (pts) with advanced renal cell carcinoma (mRCC). Background: Several small molecule tyrosine kinase inhibitors (TKI) targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results